Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatment
- 10 February 2024
- journal article
- research article
- Published by Elsevier in Chemical Engineering Journal
- Vol. 484, 149518
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82161138029, 82204317)
- Natural Science Foundation of Liaoning Province (2022-BS-162)
This publication has 242 references indexed in Scilit:
- Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis TherapyAdvanced Healthcare Materials, 2023
- A Strategy of Fenton Reaction Cycloacceleration for High‐Performance Ferroptosis Therapy Initiated by Tumor Microenvironment RemodelingAdvanced Healthcare Materials, 2023
- Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis ResistanceAdvanced Healthcare Materials, 2022
- An ROS‐Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis TherapyAdvanced Healthcare Materials, 2021
- Ultrasound‐Augmented Nanocatalytic Ferroptosis Reverses Chemotherapeutic Resistance and Induces Synergistic Tumor NanotherapyAdvanced Functional Materials, 2021
- Lipid Metabolism in FerroptosisAdvanced Biology, 2021
- Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaJAMA Surgery, 2021
- Recent Progress in the Development of Multifunctional Nanoplatform for Precise Tumor PhototherapyAdvanced Healthcare Materials, 2020
- Near Infrared‐Activatable Platinum‐Decorated Gold Nanostars for Synergistic Photothermal/Ferroptotic Therapy in Combating Cancer Drug ResistanceAdvanced Healthcare Materials, 2020
- Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor TargetingAdvanced Healthcare Materials, 2019